BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Koronyo-Hamaoui M, Sheyn J, Hayden EY, Li S, Fuchs DT, Regis GC, Lopes DHJ, Black KL, Bernstein KE, Teplow DB, Fuchs S, Koronyo Y, Rentsendorj A. Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease. Brain 2020;143:336-58. [PMID: 31794021 DOI: 10.1093/brain/awz364] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Le D, Brown L, Malik K, Murakami S. Two Opposing Functions of Angiotensin-Converting Enzyme (ACE) That Links Hypertension, Dementia, and Aging. Int J Mol Sci 2021;22:13178. [PMID: 34947975 DOI: 10.3390/ijms222413178] [Reference Citation Analysis]
2 Dobri AM, Dudău M, Enciu AM, Hinescu ME. CD36 in Alzheimer's Disease: An Overview of Molecular Mechanisms and Therapeutic Targeting. Neuroscience 2021;453:301-11. [PMID: 33212223 DOI: 10.1016/j.neuroscience.2020.11.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
3 Sharma S, Chitranshi N, Wall RV, Basavarajappa D, Gupta V, Mirzaei M, Graham SL, Klistorner A, You Y. Trans-synaptic degeneration in the visual pathway: Neural connectivity, pathophysiology, and clinical implications in neurodegenerative disorders. Surv Ophthalmol 2021:S0039-6257(21)00138-7. [PMID: 34146577 DOI: 10.1016/j.survophthal.2021.06.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
4 Xing Z, Zuo Z, Hu D, Zheng X, Wang X, Yuan L, Zhou L, Qi F, Yao Z. Influenza vaccine combined with moderate-dose PD1 blockade reduces amyloid-β accumulation and improves cognition in APP/PS1 mice. Brain Behav Immun 2021;91:128-41. [PMID: 32956831 DOI: 10.1016/j.bbi.2020.09.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Vit JP, Fuchs DT, Angel A, Levy A, Lamensdorf I, Black KL, Koronyo Y, Koronyo-Hamaoui M. Color and contrast vision in mouse models of aging and Alzheimer's disease using a novel visual-stimuli four-arm maze. Sci Rep 2021;11:1255. [PMID: 33441984 DOI: 10.1038/s41598-021-80988-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Cheng Y, Tian DY, Wang YJ. Peripheral clearance of brain-derived Aβ in Alzheimer's disease: pathophysiology and therapeutic perspectives. Transl Neurodegener 2020;9:16. [PMID: 32381118 DOI: 10.1186/s40035-020-00195-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
7 Süβ P, Lana AJ, Schlachetzki JCM. Chronic peripheral inflammation: a possible contributor to neurodegenerative diseases. Neural Regen Res 2021;16:1711-4. [PMID: 33510059 DOI: 10.4103/1673-5374.306060] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Zuroff LR, Torbati T, Hart NJ, Fuchs DT, Sheyn J, Rentsendorj A, Koronyo Y, Hayden EY, Teplow DB, Black KL, Koronyo-Hamaoui M. Effects of IL-34 on Macrophage Immunological Profile in Response to Alzheimer's-Related Aβ42 Assemblies. Front Immunol 2020;11:1449. [PMID: 32765504 DOI: 10.3389/fimmu.2020.01449] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Oosthuizen D, Sturrock ED, Sun M. Exploring the Impact of ACE Inhibition in Immunity and Disease. Journal of the Renin-Angiotensin-Aldosterone System 2022;2022:1-17. [DOI: 10.1155/2022/9028969] [Reference Citation Analysis]
10 Cao D, Veiras L, Ahmed F, Shibata T, Bernstein EA, Okwan-Duodu D, Giani JF, Khan Z, Bernstein KE. The non-cardiovascular actions of ACE. Peptides 2022;:170769. [PMID: 35182689 DOI: 10.1016/j.peptides.2022.170769] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Chen SH, Tian DY, Shen YY, Cheng Y, Fan DY, Sun HL, He CY, Sun PY, Bu XL, Zeng F, Liu J, Deng J, Xu ZQ, Chen Y, Wang YJ. Amyloid-beta uptake by blood monocytes is reduced with ageing and Alzheimer's disease. Transl Psychiatry 2020;10:423. [PMID: 33293506 DOI: 10.1038/s41398-020-01113-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
12 Dvir-szternfeld R, Castellani G, Arad M, Cahalon L, Colaiuta SP, Keren-shaul H, Croese T, Burgaletto C, Baruch K, Ulland T, Colonna M, Weiner A, Amit I, Schwartz M. Alzheimer’s disease modification mediated by bone marrow-derived macrophages via a TREM2-independent pathway in mouse model of amyloidosis. Nat Aging 2022;2:60-73. [DOI: 10.1038/s43587-021-00149-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
13 Ibanez L, Cruchaga C, Fernández MV. Advances in Genetic and Molecular Understanding of Alzheimer's Disease. Genes (Basel) 2021;12:1247. [PMID: 34440421 DOI: 10.3390/genes12081247] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Villacampa N, Heneka MT. Microglia in Alzheimer's disease: Local heroes! J Exp Med 2020;217:e20192311. [PMID: 32126139 DOI: 10.1084/jem.20192311] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Zang X, Chen S, Zhu J, Ma J, Zhai Y. The Emerging Role of Central and Peripheral Immune Systems in Neurodegenerative Diseases. Front Aging Neurosci 2022;14:872134. [DOI: 10.3389/fnagi.2022.872134] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Doustar J, Rentsendorj A, Torbati T, Regis GC, Fuchs DT, Sheyn J, Mirzaei N, Graham SL, Shah PK, Mastali M, Van Eyk JE, Black KL, Gupta VK, Mirzaei M, Koronyo Y, Koronyo-Hamaoui M. Parallels between retinal and brain pathology and response to immunotherapy in old, late-stage Alzheimer's disease mouse models. Aging Cell 2020;:e13246. [PMID: 33090673 DOI: 10.1111/acel.13246] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
17 Merde İB, Önel GT, Türkmenoğlu B, Gürsoy Ş, Dilek E, Özçelik AB, Uysal M. Synthesis of ( p‐ tolyl)‐3(2 H )pyridazinone Derivatives as Novel Acetylcholinesterase Inhibitors. ChemistrySelect 2022;7. [DOI: 10.1002/slct.202201606] [Reference Citation Analysis]
18 Xin XY, Lai ZH, Ding KQ, Zeng LL, Ma JF. Angiotensin-converting enzyme polymorphisms AND Alzheimer's disease susceptibility: An updated meta-analysis. PLoS One 2021;16:e0260498. [PMID: 34818351 DOI: 10.1371/journal.pone.0260498] [Reference Citation Analysis]
19 Mirzaei N, Shi H, Oviatt M, Doustar J, Rentsendorj A, Fuchs DT, Sheyn J, Black KL, Koronyo Y, Koronyo-Hamaoui M. Alzheimer's Retinopathy: Seeing Disease in the Eyes. Front Neurosci 2020;14:921. [PMID: 33041751 DOI: 10.3389/fnins.2020.00921] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
20 Srivastava S, Ahmad R, Khare SK. Alzheimer's disease and its treatment by different approaches: A review. Eur J Med Chem 2021;216:113320. [PMID: 33652356 DOI: 10.1016/j.ejmech.2021.113320] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
21 Smit T, Deshayes NAC, Borchelt DR, Kamphuis W, Middeldorp J, Hol EM. Reactive astrocytes as treatment targets in Alzheimer's disease-Systematic review of studies using the APPswePS1dE9 mouse model. Glia 2021;69:1852-81. [PMID: 33634529 DOI: 10.1002/glia.23981] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
22 Khurana V, Goswami B. Angiotensin converting enzyme (ACE). Clin Chim Acta 2022;524:113-22. [PMID: 34728179 DOI: 10.1016/j.cca.2021.10.029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
23 Pillaiyar T, Meenakshisundaram S, Manickam M, Sankaranarayanan M. A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery. Eur J Med Chem 2020;195:112275. [PMID: 32283298 DOI: 10.1016/j.ejmech.2020.112275] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
24 Koronyo-hamaoui M, Gaire BP, Frautschy SA, Alvarez JI. Editorial: Role of Inflammation in Neurodegenerative Diseases. Front Immunol 2022;13:958487. [DOI: 10.3389/fimmu.2022.958487] [Reference Citation Analysis]
25 Cisbani G, Rivest S. Targeting innate immunity to protect and cure Alzheimer's disease: opportunities and pitfalls. Mol Psychiatry 2021. [PMID: 33854189 DOI: 10.1038/s41380-021-01083-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
26 Campos J, Pacheco R. Involvement of dopaminergic signaling in the cross talk between the renin-angiotensin system and inflammation. Semin Immunopathol 2020;42:681-96. [PMID: 32997225 DOI: 10.1007/s00281-020-00819-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]